Image

Asia-Pacific Point-of-Care Testing (POCT) Market – Industry Trends and Forecast to 2029

Healthcare

Image

Asia-Pacific Point-of-Care Testing (POCT) Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • May 2022
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Point-of-Care Testing (POCT) Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 29.00 Billion
Diagram Market Size (Forecast Year) USD 64.46 Billion
Diagram CAGR %

Major Markets Players

  • Mentioned in the data

Asia-Pacific Point-of-Care Testing (POCT) Market, By Product (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing and Other POC Products), Application (Blood Transfusion, Cardiac Monitoring, Coagulation, Blood Glucose, Haematology, Non- Invasive SPO2 Monitoring, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, Vital Sign Monitoring and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays), Prescription Mode (Prescription-Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays and Hematology), End-User (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgery Centers and Others), Distribution Channel (Direct Tender and Retail Pharmacies) – Industry Trends and Forecast to 2029

Asia-Pacific Point-of-Care Testing (POCT) Market

Market Analysis and Size

Point-of-care testing, which is defined as testing that may be done in close proximity to the patient and allows a medical choice to be taken right away based on the results and monitoring. point-of-care testing (POCT), also known as with-patient testing, allows doctors to assess accurate real-time, lab-quality diagnostic results in minutes rather than hours. It guarantees that patients get the most effective and efficient care possible, whenever and wherever they need it.

Data Bridge Market Research analyses that the point-of-care testing (POCT) market which was USD 29 billion in 2021, would rocket up to USD 64.46 billion by 2029, and is expected to undergo a CAGR of 10.5% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

POC tests are not as highly preferred as central laboratory tests because of low volume and high cost. This puts additional strain on the billing system, which must give distinct codes for POC tests. This might result in billing errors by inexperienced or newly hired employees, as well as failure to enter data into the data management system due to mismatched test codes.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing and Other POC Products), Application (Blood Transfusion, Cardiac Monitoring, Coagulation, Blood Glucose, Haematology, Non- Invasive SPO2 Monitoring, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, Vital Sign Monitoring and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays), Prescription Mode (Prescription-Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays and Hematology), End-User (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgery Centers and Others), Distribution Channel (Direct Tender and Retail Pharmacies)

Countries Covered

China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)

Market Players Covered

Abbott (U.S), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S), Danaher (U.S), Sekisui Diagnostics (U.S), Trinity Biotech (Ireland), bioMérieux (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S), Beckman Coulter, Inc. (U.S), PTS Diagnostics (U.S), Nova Biomedical (U.S), Chembio Diagnostics, Inc. (U.S), Quidel Corporation (U.S) and Sienco, Inc (U.S)

Market Opportunities

  • Technological advancement in lateral flow assay
  • Advances in component materials

Point-of-Care Testing (POCT) Market Dynamics

Drivers

  • Upward trend in disease prevalence in the developing countries

Chronic diseases and acute infections are on the rise in developing countries, owing to a lack of health awareness, poor medical infrastructure, and a sedentary lifestyle, among other causes. As a result of these circumstances, diagnosis and treatment are delayed, as is the quality of care obtained. The need for point-of-care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size.

  • Benefits related with OTC-based test

The point of care testing market for TC tests is expected to develop at a 7.1% CAGR through 2027, owing to an increase in OTC testing such as pregnancy tests and blood glucose tests that deliver results in a matter of seconds. These examinations do not necessitate the use of a skilled specialist and may be performed by individuals themselves, propelling the industry forward. The First Response kit, for example, is a quick pregnancy test that provides a response in 60 seconds. Accu-Chek active blood glucose metre kits also give customers with readings in 5 seconds, boosting market demand.

  • Increasing incidence rate of diabetes and obesity lead to cardiovascular illness

The increased prevalence of diabetes and obesity, the point of care testing market for cardio metabolic testing is predicted to exceed USD 5.3 billion by 2027. The cardiometabolic test also determines the percentage level of Docosahexaenoic acid (DHA) and eicosapentanoic acid (EPA) in red blood cell membrane.This also aids in the identification of new risk factors for cardiac arrest and other heart-related disorders.

Opportunities

  • Technological advancement in lateral flow assay

The market for lateral flow assays in point of care testing is expected to reach USD 11.8 billion by 2027. The industry's growth will be aided by the launch of novel products that will allow for rapid advancement in the research and development (R&D) of point-of-care testing (POCT) diagnostic tools. In addition, advances in component materials, reader technologies, reagents, and sensitivity increase have made quantitative results more possible with the use of lateral flow assay, supporting sector growth.

Restraints/Challenges

  • Stringent regulatory policies

Due to tight and time-consuming regulatory requirements, the point of care testing industry is growing slowly. With the expanding area of use and increased adoption in developing economies, regulators are placing a greater emphasis on point-of-care testing (POCT) compliance, safety, and usability. Point-of-care testing are classed as class II medical devices by the US Food and Drug Administration. These devices provide a reasonable guarantee of the device's effectiveness and safety.

  • Lack of alignment with definitive central lab methods

Unsuitable indications for the performance of the test, inappropriate sampling times and techniques, a lack of information about the patient's condition, and other factors such as fasting before functional tests or variations in posture/position during similar tests are all examples of pre-analytical errors for POC testing.

This point-of-care testing (POCT) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point-of-care testing (POCT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Point-of-Care Testing (POCT) Market

The growing use of point-of-care tests that can quickly identify COVID-19, the point-of-care diagnostics market will rise significantly in 2022. Point-of-care testing has become an important diagnostic technique due to the necessity for quick diagnostic results. Rapid antigen testing kits that can be utilised efficiently in point-of-care settings are in high demand due to the rapidly increasing number of COVID-19 cases and the growing pressure on governments to enhance patient management. Different significant reasons projected to fuel the long-term growth of the point-of-care diagnostics market are the rising prevalence of other respiratory disorders around the world, the shift toward decentralised diagnostics, and enhanced access to point-of-care devices through online platforms.

Recent Development

 Roche introduced its Cobas Pulse System in select countries accepting the CE Mark in January 2022. This is the latest generation of linked point-of-care solutions for professional blood glucose management from Roche Diagnostics.

 In October 2021, Thermo Fisher Scientific announced that it had received FDA Emergency Use Authorization (EUA) to run COVID-19 tests with the Spectrum Solutions SpectrumDNA SDNA-1000 collection device, a high-throughput, automated COVID-19 testing system on the Amplitude Solution, using a new saliva sample collection method.

 The SPECIFIC REVEAL Rapid AST system was co-exclusively distributed in Europe by bioMérieux and Specific Diagnostics in June 2021. The system works in tandem with bioMérieux's BIOFIRE BCID2.

Asia-Pacific Point-of-Care Testing (POCT) Market Scope

The point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Product

  • Glucose Monitoring
  • Strips
  • Meters
  • Lancets
  • Cardiometabolic testing
  • Cardiac marker testing
  • hsTnl
  • BNP
  • D-dimer
  • CK-MB
  • Myoglobin
  • Others
  • Blood gas/electrolytes testing
  • HBA1C testing
  • Infectious disease testing
  • Influenza testing
  • HIV testing
  • Hepatitis C testing
  • Sexually Transmitted Disease (STD) testing
  • Healthcare-Associated Infection (HAI) testing
  • Respiratory infection testing
  • Tropical disease testing
  • Other infectious diseases testing
  • Coagulation testing
  • PT/INR testing
  • Activated Clotting Time (ACT/APTT) testing
  • Pregnancy and fertility testing
  • Pregnancy testing
  • Fertility testing
  • Tumor/Cancer marker testing
  • Urinalysis testing
  • Cholesterol testing
  • Hematology testing
  • Drugs-of-abuse testing
  • Fecal occult testing
  • Others

Technology

  • Lateral flow assays
  • Dipsticks
  • Microfluidics
  • Molecular diagnostics
  • Immunoassays
  • Agglutination assays
  • Flow-through
  • Solid phase
  • Biosensors

Prescription

  • OTC testing
  • Prescription-based testing

Application

  • Cardio metabolic testing
  • Infectious disease testing
  • Nephrology testing
  • Drug-of-Abuse (DoA) testing
  • Blood glucose testing
  • Pregnancy testing
  • Cancer biomarker testing
  • Other applications

 End-user

  • Hospitals
  • Diagnostic centers
  • Research laboratories
  • Home-care settings
  • Others

Distribution Channel

  • Direct tender
  • Retail Pharmacies

Point-of-Care Testing (POCT) Market Regional Analysis/Insights

The point-of-care testing (POCT) market is analysed and market size insights and trends are provided by country, product, technology, prescription, application end-user and distribution channel as referenced above.

The countries covered in the point-of-care testing (POCT) market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China is expected to dominate the market because point-of-care testing (POCT) products in China have a massive application space in the fields of hospital operation, emergency department, intensive care, chronic disease prevention and control, public health emergencies, county-level medical institution construction, and new rural supportive medical care.

Japan will dominate the market due to an increasing number of people suffering from HIV and other illnesses, which will result in a high approval rate for point-of-care testing devices in the country. India is the dominant country due to the high prevalence of diseases among its people.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Healthcare Infrastructure growth Installed base and New Technology Penetration

The point-of-care testing (POCT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point-of-care testing (POCT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point-of-care testing (POCT) market. The data is available for historic period 2010-2020.

Competitive Landscape and Point-of-Care Testing (POCT) Market Share Analysis

The point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point-of-care testing (POCT) market.

Some of the major players operating in the point-of-care testing (POCT) market are:

  • Abbott (U.S)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • BD (U.S)
  • Siemens Healthcare Private Limited (Germany)
  • Bio-Rad Laboratories, Inc. (U.S)
  • Danaher (U.S)
  • Sekisui Diagnostics (U.S)
  • Trinity Biotech (Ireland)
  • bioMérieux (France)
  • EKF Diagnostics (Germany)
  • AccuBioTech Co., Ltd. (China)
  • Instrumentation Laboratory (U.S)
  • Beckman Coulter, Inc. (U.S)
  • PTS Diagnostics (U.S)
  • Nova Biomedical (U.S)
  • Chembio Diagnostics, Inc. (U.S)
  • Quidel Corporation (U.S)
  • Sienco, Inc (U.S)


SKU-

LIST OF TABLES 

TABLE 1 DIFFERENT ASSOCIATIONS FOR DIAGNOSTICS

TABLE 2 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 3 ASIA-PACIFIC GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 4 ASIA-PACIFIC INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 5 ASIA-PACIFIC CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 6 ASIA-PACIFIC PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 7 ASIA-PACIFIC HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 8 ASIA-PACIFIC RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 9 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)

TABLE 10 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)

TABLE 11 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)

TABLE 12 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)

TABLE 13 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY TECHNOLOGIES, 2018-2027 (USD MILLION)

TABLE 14 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 15 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 16 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 17 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 18 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 19 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 21 ASIA-PACIFIC CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 22 ASIA-PACIFIC INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 23 ASIA-PACIFIC PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 24 ASIA-PACIFIC CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 27 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 31 ASIA-PACIFIC POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 32 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 33 ASIA-PACIFIC POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 34 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 35 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 36 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 37 CHINA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 38 CHINA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 39 CHINA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 40 CHINA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 41 CHINA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 42 CHINA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 43 CHINA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 44 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 45 CHINA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 46 CHINA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 47 CHINA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 48 CHINA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 49 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 50 CHINA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 51 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 52 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 53 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 54 JAPAN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 55 JAPAN CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 56 JAPAN INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 57 JAPAN PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 58 JAPAN CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 59 JAPAN HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 60 JAPAN RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 61 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 62 JAPAN HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 63 JAPAN WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 64 JAPAN VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 65 JAPAN POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 66 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 67 JAPAN POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 68 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 69 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 70 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 71 INDIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 72 INDIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 73 INDIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 74 INDIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 75 INDIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 76 INDIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 77 INDIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 78 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 79 INDIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 80 INDIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 81 INDIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 82 INDIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 83 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 84 INDIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 85 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 86 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 87 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 88 SOUTH KOREA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 89 SOUTH KOREA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 90 SOUTH KOREA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 91 SOUTH KOREA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 92 SOUTH KOREA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 93 SOUTH KOREA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 94 SOUTH KOREA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 95 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 96 SOUTH KOREA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 97 SOUTH KOREA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 98 SOUTH KOREA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 99 SOUTH KOREA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 100 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 101 SOUTH KOREA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 102 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 103 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 104 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 105 GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 106 AUSTRALIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 107 AUSTRALIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 108 AUSTRALIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 109 AUSTRALIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 110 AUSTRALIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 111 AUSTRALIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 112 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 113 AUSTRALIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 114 AUSTRALIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 115 AUSTRALIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 116 AUSTRALIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 117 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 118 AUSTRALIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 119 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 120 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 121 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 122 SINGAPORE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 123 SINGAPORE CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 124 SINGAPORE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 125 SINGAPORE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 126 SINGAPORE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 127 SINGAPORE HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 128 SINGAPORE RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 129 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 130 SINGAPORE HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 131 SINGAPORE WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 132 SINGAPORE VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 133 SINGAPORE POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 134 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 135 SINGAPORE POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 136 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 137 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 138 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 139 MALAYSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 140 MALAYSIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 141 MALAYSIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 142 MALAYSIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 143 MALAYSIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 144 MALAYSIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 145 MALAYSIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 146 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 147 MALAYSIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 148 MALAYSIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 149 MALAYSIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 150 MALAYSIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 151 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 152 MALAYSIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 153 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 154 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 155 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 156 THAILAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 157 THAILAND CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 158 THAILAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 159 THAILAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 160 THAILAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 161 THAILAND HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 162 THAILAND RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 163 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 164 THAILAND HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 165 THAILAND WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 166 THAILAND VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 167 THAILAND POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 168 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 169 THAILAND POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 170 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 171 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 172 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 173 INDONESIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 174 INDONESIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 175 INDONESIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 176 INDONESIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 177 INDONESIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 178 INDONESIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 179 INDONESIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 180 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 181 INDONESIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 182 NDONESIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 183 INDONESIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 184 INDONESIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 185 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 186 INDONESIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 187 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 188 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 189 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 190 PHILIPPINES GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)

TABLE 191 PHILIPPINES CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 192 PHILIPPINES INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 193 PHILIPPINES PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 194 PHILIPPINES CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 195 PHILIPPINES HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 196 PHILIPPINES RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

TABLE 197 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 198 PHILIPPINES HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 199 PHILIPPINES WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)

TABLE 200 PHILIPPINES VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)

TABLE 201 PHILIPPINES POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)

TABLE 202 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)

TABLE 203 PHILIPPINES POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)

TABLE 204 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)

TABLE 205 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)

TABLE 206 REST OF ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)

 

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Asia-Pacific Point-of-Care Testing (POCT) Market value is expected USD 64.46 billion by 2029.
The Asia-Pacific Point-of-Care Testing (POCT) Market is projected to grow at a CAGR of 10.5% during the forecast by 2029.
On the basis of application, the Asia-Pacific Point-of-Care Testing (POCT) Market is segmented into Blood Transfusion, Cardiac Monitoring, Coagulation, Blood Glucose, Haematology, Non- Invasive SPO2 Monitoring, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, Vital Sign Monitoring and Others.
On the basis of product, the Asia-Pacific Point-of-Care Testing (POCT) Market is segmented into Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing and Other POC Products.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials